1. BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer. Issue 6 (11th September 2018) Authors: Tsibulak, Irina; Wieser, Verena; Degasper, Christine; Shivalingaiah, Giridhar; Wenzel, Sören; Sprung, Susanne; Lax, Sigurd; Marth, Christian; Fiegl, Heidelinde; Zeimet, Alain Journal: British journal of cancer Issue: Volume 119:Issue 6(2018) Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort. (1st February 2021) Authors: Tsibulak, Irina; Wieser, Verena; Welponer, Hannah; Leitner, Katharina; Hackl, Hubert; Marth, Christian; Fiegl, Heidelinde; Zeimet, Alain G. Journal: Acta oncologica Issue: Volume 60:Number 2(2021) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TNFα signalling predicts poor prognosis of patients with endometrial cancer. (6th April 2020) Authors: Wieser, Verena; Abdel Azim, Samira; Sprung, Susanne; Knoll, Katharina; Kögl, Johanna; Hackl, Hubert; Marth, Christian; Zeimet, Alain G; Fiegl, Heidelinde Journal: Carcinogenesis Issue: Volume 41:Number 8(2020) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer. Issue 3 (16th February 2019) Authors: Wieser, Verena; Tsibulak, Irina; Degasper, Christine; Welponer, Hannah; Leitner, Katharina; Parson, Walther; Zeimet, Alain G.; Marth, Christian; Fiegl, Heidelinde Journal: Cancer science Issue: Volume 110:Issue 3(2019) Page Start: 1117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗